Profile
Karen M.
Nichols is currently the Chief Regulatory Officer at the International Society for Cellular Therapy since 2007.
Prior to this, she held the position of Vice President-Regulatory & Quality at NantKwest, Inc. and Magenta Therapeutics, Inc. Ms. Nichols completed her undergraduate and graduate degrees from The State University of New York and also holds a graduate degree from Suffolk University Law School, which was conferred in 1996.
Karen M. Nichols active positions
| Companies | Position | Start |
|---|---|---|
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services Conducts cell-based research, processing, and manipulation, and publishes researched materials | General Counsel | 31/12/2006 |
Former positions of Karen M. Nichols
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | General Counsel | - |
| IMMUNITYBIO, INC. | General Counsel | - |
Training of Karen M. Nichols
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services Conducts cell-based research, processing, and manipulation, and publishes researched materials | Commercial Services |
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University Law School
Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
- Stock Market
- Insiders
- Karen M. Nichols
















